Lysophosphatidylcholine Acyltransferase 2 (LPCAT2) (N-Term) Peptide
Quick Overview for Lysophosphatidylcholine Acyltransferase 2 (LPCAT2) (N-Term) Peptide (ABIN8104690)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- Lpcat2 Peptide - N-terminal region
-
Sequence
- NENAQTPLVG RLLRALQPVL VSRVDPDSRK NTINEIKKRA TSGGEWPQIL
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-Lpcat2 Antibody (ARP47360_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LPCAT2 (Lysophosphatidylcholine Acyltransferase 2 (LPCAT2))
-
Background
-
Background Information: Lpcat2 possesses both acyltransferase and acetyltransferase activities. Activity is calcium-dependent. It is involved in platelet-activating factor (PAF) biosynthesis by catalyzing the conversion of the PAF precursor, 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) into 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF). It also converts lyso-PAF to 1-alkyl-phosphatidylcholine (PC), a major component of cell membranes and a PAF precursor. Under resting conditions, acyltransferase activity is preferred. Upon acute inflammatory stimulus, acetyltransferase activity is enhanced and PAF synthesis increases.
Alternative Symbols: A330042H22, Aytl1, LPCAT2, lpafat1, Aytl1a
-
Molecular Weight
- 60kDa
-
Gene ID
- 270084
-
NCBI Accession
- NP_766602
-
UniProt
- Q8BYI6
Target
-